Literature DB >> 25130071

Isolation of Enterococcus faecium NM113, Enterococcus faecium NM213 and Lactobacillus casei NM512 as novel probiotics with immunomodulatory properties.

Nahla M Mansour1, Holger Heine, Sania M Abdou, Mohamed E Shenana, Mohamed K Zakaria, Ahmed El-Diwany.   

Abstract

Probiotics, defined as living bacteria that are beneficial for human health, mainly function through their immunomodulatory abilities. Hence, these microorganisms have proven successful for treating diseases resulting from immune deregulation. The aim of this study was to find novel candidates to improve on and complement current probiotic treatment strategies. Of 60 lactic acid bacterial strains that were isolated from fecal samples of healthy, full-term, breast-fed infants, three were chosen because of their ability to activate human immune cells. These candidates were then tested with regard to immunomodulatory properties, antimicrobial effects on pathogens, required pharmacological properties and their safety profiles. To identify the immunomodulatory structures of the selected isolates, activation of specific innate immune receptors was studied. The three candidates for probiotic treatment were assigned Enterococcus faecium NM113, Enterococcus faecium NM213 and Lactobacillus casei NM512. Compared with the established allergy-protective strain Lactococcus lactis G121, these isolates induced release of similar amounts of IL-12, a potent inducer of T helper 1 cells. In addition, all three neonatal isolates had antimicrobial activity against pathogens. Analysis of pharmacological suitability showed high tolerance of low pH, bile salts and pancreatic enzymes. In terms of safe application in humans, the isolates were sensitive to three antibiotics (chloramphenicol, tetracycline and erythromycin). In addition, the Enterococcus isolates were free from the four major virulence genes (cylA, agg, efaAfs and ccf). Moreover, the isolates strongly activated Toll-like receptor 2, which suggests lipopeptides as their active immunomodulatory structure. Thus, three novel bacterial strains with great potential as probiotic candidates and promising immunomodulatory properties have here been identified and characterized.
© 2014 The Societies and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Allergy; immunomodulation; lactic acid bacteria; probiotics

Mesh:

Substances:

Year:  2014        PMID: 25130071     DOI: 10.1111/1348-0421.12187

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

1.  Unique Microbial Catabolic Pathway for the Human Core N-Glycan Constituent Fucosyl-α-1,6-N-Acetylglucosamine-Asparagine.

Authors:  Jimmy E Becerra; Jesús Rodríguez-Díaz; Roberto Gozalbo-Rovira; Martina Palomino-Schätzlein; Manuel Zúñiga; Vicente Monedero; María J Yebra
Journal:  mBio       Date:  2020-01-14       Impact factor: 7.867

2.  Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.

Authors:  Yan Wang; Qian Tong; Shu-Rong Ma; Zhen-Xiong Zhao; Li-Bin Pan; Lin Cong; Pei Han; Ran Peng; Hang Yu; Yuan Lin; Tian-Le Gao; Jia-Wen Shou; Xiao-Yang Li; Xian-Feng Zhang; Zheng-Wei Zhang; Jie Fu; Bao-Ying Wen; Jin-Bo Yu; Xuetao Cao; Jian-Dong Jiang
Journal:  Signal Transduct Target Ther       Date:  2021-02-24

3.  Probiotic Potential Analysis and Safety Evaluation of Enterococcus durans A8-1 Isolated From a Healthy Chinese Infant.

Authors:  Yi Zhou; Lu Shi; Juan Wang; Jia Yuan; Jin Liu; Lijuan Liu; Rong Da; Yue Cheng; Bei Han
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640

4.  Exopolysaccharide of Enterococcus faecium L15 promotes the osteogenic differentiation of human dental pulp stem cells via p38 MAPK pathway.

Authors:  Hyewon Kim; Naeun Oh; Mijin Kwon; Oh-Hee Kwon; Seockmo Ku; Jeongmin Seo; Sangho Roh
Journal:  Stem Cell Res Ther       Date:  2022-09-02       Impact factor: 8.079

5.  Enterococcus faecium L-15 Cell-Free Extract Improves the Chondrogenic Differentiation of Human Dental Pulp Stem Cells.

Authors:  Hyewon Kim; Sangkyu Park; Kichul Kim; Seockmo Ku; Jeongmin Seo; Sangho Roh
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.